We evaluated whether the dodecylamine derivative of hydroxocobalamin acts as a potent inhibitor of cobalamin-dependent enzymes in an African green monkey kidney cell, COS-7. When the dodecylamine derivative (1.0 μmol/L) did not show any cytotoxicity in the cultured cells, the derivative could not affect methylmalonyl-CoA mutase (holo-enzyme) activity, but significantly inhibit methionine synthase (holo-enzyme) activity in the cell homogenates of COS-7 grown in 1.0 μmol/L hydroxocobalamin-supplemented medium. An immunoblot analysis indicated that the dodecylamine derivative could not decrease the protein level of methionine synthase, but significantly inhibit the enzyme activity.
Introduction
Cyanocobalamin (or vitamin B 12 , Cbl) is an essential nutrient for humans, which have a complex process for gastrointestinal absorption of dietary Cbl [1] [2] . The Cbl released from food protein is bound to haptocorrin (salivary Cbl-binding protein) and then intrinsic factor (IF, gastric Cbl-binding protein) in the proximal ileum. The IF-Cbl complex can enter mucosal cells in the distal ileum by receptor-mediated endocytosis and thereafter the Cbl absorbed is bound to transcobalamin II to circulate in blood. After being taken up by the target cells, Cbl is converted into the two coenzyme forms, 5'-deoxyadenosylcobalamin and methylcobalamin, which function as the coenzyme of methylmalonyl-CoA mutase (EC 5.4.99.2) [3] and methionine synthase (EC 2.1.1.13) [4] , respectively.
The major signs of Cbl deficiency are megaloblastic anemia and neuropathy [5] . The underlying cause(s) of various symptoms (developmental disorder, metabolic abnormalities, and neuropathy) caused by Cbl deficiency are not still understood [6] . To investigate the molecular mechanisms of the metabolic disorders linked to such diseases, Cbl-deficient animal models are absolutely required. However, they cannot be readily prepared because animals (e.g. rats) must be fed with a Cbl deficient diet for long periods to make them Cbl-deficient [7] . The Cbl analogue with a modification of the side chain of C-ring, Cbl [c-lactam], has been reported to antagonize Cbl in the cultured HL 60 cells [8] . Subcutaneous administration of hydroxocobalamin (OH-Cbl) [c-lactam] to rats has indicated that the analogue has the ability to act as a potent inhibitor of the mammalian Cbl-dependent enzymes to make the rats Cbl-deficient [9] . However, considerably high concentration of OH-Cbl [c-lactam] must be administrated for several weeks with osmotic mini pumps in order to prepare Cbl-deficient rats because IF hardly binds OH-Cbl [c-lactam] [9] .
McEwan et al. [10] have demonstrated the preparation of ribose-5'-carbamate derivatives of Cbl; some of the alkylamine derivatives have considerably high affinity for IF. Our preliminary experiments indicate that the prepared alkylamine derivatives did not show any biological activity as Cbl in certain Cbl-requiring microorganisms. Remarkably they could inhibit significantly Cbl-dependent enzyme activities at the in vitro experiments. If the Cbl alkylamine derivatives act as potent inhibitors of mammalian Cbl-dependent enzymes in vivo, Cbl-deficient animals would be readily prepared by oral administration of the derivatives.
Here we described characterization of the Cbl alkylamine derivatives as potent inhibitors of the Cbl-dependent enzymes in the mammalian cultured cells.
Materials and Methods

Materials
CN-Cbl, 1,1'-carbonyldiimidazole, hexylamine, dodecylamine, and dexadecylamine were purchased from Wako Pure Chemical Industries (Osaka, Japan). OH-Cbl was obtained from Sigma (St. Louis, USA). Phenyl-Toyopearl 650M was purchased from TOSHO Corporation (Tokyo, Japan). An antibody for human methionine synthase (anti-MTR antibody) was obtained from Abcam ® Japan (Tokyo, Japan).
Preparation of Alkylamine Derivatives of CN-Cbl
Alkylamine derivatives of CN-Cbl were prepared according to the method of McEwan et al. [10] . In briefly, solid 1,1'-carbonyldiimidazole (26 mg) was added to CN-Cbl (0.1 g) which had been dissolved in dimethyl sulfoxide (1.2 mL) at 30˚C and the mixture was stirred at 300 rpm for 25 min. Hexylamine, dodecylamine, or hexadecylamine (each at 0.27 mmol) was added to the mixture and then stirred at 300 rpm for 24 h at a room temperature (25˚C) (Figure 1 ). Cbl compounds were extracted twice from the mixture with 2 mL of phenol/dichloromethane (1:2, v/v) and then re-extracted twice from the combined phenol fractions with 2 mL of distilled water. The water-soluble fractions were combined and put on a column (2.4 × 24 cm) of a TSK gel Phenyl-Toyopearl 650 M which had been washed with 250 mL of 25% (v/v) ethanol. Unmodified and modified CN-Cbl compounds were eluted with 250 mL of 25% (v/v) and 60% (v/v) ethanol solution, respectively. The product fractions were combined and evaporated under the reduced pressure and the residue was dissolved in 5 mL of 80% (v/v) ethanol. Each product was further purified with silica gel 60 TLC as a solvent (1-butanol:2-propanol:water = 10:7:10, v/v/v). After the TLC sheet had been dried, each derivative was collected, extracted with 80% (v/v) methanol solution, and evaporated to dryness under the reduced pressure. The residual fraction was dissolved in a small amount of 18% (v/v) acetonitrile and then purified with a reversed-phase HPLC column (Wakosil-II5C18RS φ4.6 × 150 mm) using a Shimadzu HPLC apparatus (LC10 system, Kyoto, Japan). These CN-Cbl derivatives were eluted with a linear gradient of acetonitrile (18% -28% for 8.5 min and 28% -100% for 13 min) at 40˚C and monitored by measuring absorbance at 254 nm. The flow rate was 1.0 mL/min. Each peak fraction was collected, evaporated to dryness under the reduced pressure, and used for the following experiments. Hexylamine, dodecylamine, and hexadecylamine derivatives of CN-Cbl were dissolved in distilled water and their concentrations were determined with λ 361 = (ε = 10,500, 16,900 and 20,000, respectively) as described in the cited reference [10] .
Preparation of CN-Cbl [c-Lactam]
CN-Cbl [c-lactam] was prepared from CN-Cbl by the method as described previously [11] .
Preparation of Alkylamine and c-Lactam Derivatives of OH-Cbl
The above alkylamine and c-lactam derivatives of CN-Cbl were dissolved in 5.0 mL of distilled water and bubbled with N 2 gas for 20 min and reduced with NaH 4 . Each treated solution was neutralized with 1.0 mol/L HCl. Most of the CN-Cbl derivatives were converted to the respective OH-Cbl derivatives. After the formed OH-B 12 derivatives were desalted with a Sep-pak Vac 20 cc (5 g) C18 cartridge (Waters Corp.), they were separated from the remaining CN-Cbl derivatives with silica gel 60 TLC under the same conditions as described above. After the TLC sheet had been dried, each OH-Cbl derivative was collected, extracted with 80% (v/v) methanol solution, evaporated to dryness under the reduced pressure.
Cell Culture
COS-7 (African green monkey kidney) cells were cultured in 10 mL Dulbecco's modified Eagle's medium, containing 10% (v/v) fetal bovine serum, penicillin (100 units/mL) and streptomycin (100 μg/mL), on a 100 mm dish at 37˚C in a humidified 5% CO 2 -95% air (v/v) atmosphere. Authentic OH-Cbl was added into the medium at a varied concentration (0, 0.1, and 1.0 μmol/L) in the presence or absence of 1.0 μmol/L alkylamine and c-lactam derivatives of OH-Cbl. After reaching confluence, the cells were harvested and homogenised in 100 mmol/L potassium phosphate buffer (pH 7.0), containing leupeptin (1 mg/mL), aprotinin (10 mg/mL) and 0.1 mmol/L 4-(2-aminoethyl)-benzenesulfonyl fluoride, with a Teflon homogenizer at 4˚C. The homogenate was centrifuged at 10,000 × g for 10 min at 4˚C, and the supernatant fraction obtained was used as a crude enzyme solution for the enzyme assay.
Enzyme Assay
Methylamlonyl-CoA mutase (MCM) and methionine synthase (MS) activities were assayed by HPLC methods 
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described previously [12] [13] . Total (holoenzyme and apoenzyme) and holo enzyme activities were determined in the presence or absence of each Cbl cofactor (MCM for 5'-deoxyadenosylcobalamin and MS for methylcobalamin).
Western Blotting
The cell homogenate described above was subjected to SDS-PAGE. Proteins in the gel were electroblotted to a polyvinylidene difluoride membrane. The membrane was treated with an anti-MS antibody, and immunoreactive proteins on the membrane were detected by a chemiluminescent method using a commercial kit (Super Signal West Pico Chemiluminescent substrate system; Pierce, Rockford, IL, USA) with horseradish peroxidase-conjugated goat anti-rabbit IgG antibodies. Digital images were obtained with a luminescent image analyzer (LAS-1000 Plus; Fuji Film, Tokyo, Japan).
Statistical Analyses
Total-and holo-MCM and MS activities of the COS-7 cells treated with or without the alkylamine derivatives of OH-Cbl and OH-Cbl [c-lactam] were statistically analyzed by one-way ANOVA, and post hoc analyses were done by the Tukey's multi-comparison test. These analyses were performed with GraphPad Prism ® for windows version 5.03 (GraphPad Software Inc., La Jolla, CA 92037 USA). All data are expressed as means and standard deviations, and statistical significance is defined as p < 0.05.
Results and Discussion
Effects of Three Alkylamine Derivatives of OH-B 12 on MCM and MS Activities of COS-7 Cells
The prepared alkylamine [hexylamine (1), dodecylamine (2), and hexadecylamine (3) in Figure 2 ] derivatives of OH-Cbl (1.0 μmol/L) were evaluated as Cbl-dependent enzyme inhibitors in total and holo-MCM and MS activities of the COS-7 cells grown in 0.1 mmol/L OH-Cbl-supplemented medium (Figure 3 ). All alkylamine derivatives did not affect the enzyme activity of total MCM (holo-and apo-enzymes), but significantly inhibited the enzyme activity of the holo-MCM. While the addition of each alkylamine derivative showed the same degrees of inhibition in the enzyme activities of both total and holo-MS. The dodecylamine and hexadecylamine derivatives are stronger inhibitors in both holo-enzymes (about 30% and 45% activities of MCM and MS of the control cells, respectively) than the hexylamine derivative. All alkylamine derivatives used did not show any cytotoxicity in the cultured COS-7 under the experimental conditions. McEwan et al. [10] have demonstrated that the dodecylamine derivative of Cbl can bind IF considerably (36% of intact Cbl), but hexadecylamine derivative cannot. We selected the OH-Cbl dodecylamine derivative for further experiments.
Effect of the OH-Cbl Dodecylamine Derivative and OH-Cbl [c-Lactam] on MCM Activity of COS-7 Cells
We evaluated effects of the dodecylamine derivative of OH-Cbl (1.0 μmol/L) on total and holo-MCM activities of the cells grown in OH-Cbl (at 0, 0.1, and 1.0 μmol/L)-supplemented medium, compared with the OH-Cbl [c-lactam] that is known as the Cbl-dependent enzyme inhibitor [8] [9] . When total MCM activity was significantly decreased with increase in concentration of the added OH-Cbl, 1.0 μmol/L dodecylamine and c-lactam derivatives did not affect the total enzyme activity at each concentration of authentic OH-Cbl (Figure 4) . The dodecylamine and c-lactam derivatives of OH-Cbl, however, inhibited significantly the holo-MCM activity (about 60% activity of the control) in the presence of 0.1 μmmol/L authentic OH-Cbl. Although the dodecylamine derivative did not affect any holo-MCM activity in the presence of 1.0 μmmol/L authentic OH-Cbl, OH-Cbl [c-lactam] could inhibit about 17% of the holo-enzyme activity.
Effect of the OH-Cbl Dodecylamine Derivative and OH-Cbl [c-Lactam] on MS Activity of COS-7 Cells
One μmol/L dodecylamine derivative could inhibit significantly both total and holo-MS enzyme activities (about 47% and 45% activity of the control, respectively, in the presence of 1.0 μmol/L OH-Cbl), while OH-Cbl [c-lactam] did not inhibit both total and holo-enzyme activities of the cells grown in the presence of 1.0 μmol/L OH-Cbl. Most MS has been reported to exist as the holo-enzyme in mammalian cells [14] (Figure 5 ). Although we have no information available on the mechanism of inhibition of MS by the OH-Cbl dodecylamine derivative, it is possible that the OH-Cbl derivative competitively inhibits MS.
Western Blot Analysis of MS Protein in the Cell Homogenates of the COS-7 Treated with or without Various Concentration of the OH-Cbl Dodecylamine Derivative
For further elucidation of the decrease in the MS activity in the dodecylamine derivative-treated cells, MS protein expression was examined by SDS-PAGE followed by immunobloting with an antibody of human MS. As shown in Figure 6 , the expression level of MS protein was significantly increased with dose-dependent manner by the addition of authentic OH-Cbl. The dodecylamine derivative could hardly affect the MS protein levels at each OH-Cbl concentration, indicating that the dodecylamine derivative could not inhibit the MS protein level, but inhibit MS enzyme activity. These results indicate that the dodecylamine derivative of OH-Cbl acts as a potent inhibitor of the Cbl-dependent MS, the key enzyme involved in various methylation reaction (DNA, phospholipids, and so on) via S-adenosylmethionine [15] . Since the OH-Cbl dodecylamine derivative is simply prepared over considerably high yield (~50%) relative to OH-Cbl [c-lactam], the dodecylamine derivative would be a useful tool to prepare Cbl-deficient mammalian cells and to elucidate the metabolic disorders caused by the reduced enzyme activity of MS which exerts an important influence on the cellular metabolisms. Moreover, Cbl dodecylamine derivative shows high affinity binding of IF [10] , suggesting that Cbl deficiency in mammals may be readily induced by oral or intravenous administration of this compound. 
